在患有婴儿发作的遗传性症的患者中分析初始发作特征
Youngkyu Shim1, Hunmin Kim2, Jong Hee Chae3
1Department of Pediatrics, Korea University Ansan Hospital, Korea University College of Medicine, 123, Jeokgeum-Ro, Danwongu, Ansan-Si, Gyeonggi-do 15355, Republic of Korea.
Brain & development
|January 9, 2025
概括
与SCN1A突变相关的婴儿发作的遗传常常会出现长时间的和发烧. 非SCN1A可能会出现发作集群,而通道阻断剂会使SCN1A病例恶化,但对其他病例有益.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 是一种病.
背景情况:
- 婴儿发作的遗传 (IOGE) 提出了独特的诊断和管理挑战.
- 基因突变,特别是SCN1A,是IOGE的重要贡献者.
- 了解不同的临床特征和治疗反应对于有效的患者护理至关重要.
研究的目的:
- 研究婴儿发病遗传的初始临床特征.
- 为了比较SCN1A突变患者与其他遗传突变患者之间的发作变量和对管阻断剂的反应.
主要方法:
- 对122名患有婴儿发病遗传的患者进行了回顾性分析.
- 分类为SCN1A突变组 (58名患者) 和非SCN1A突变组 (64名患者).
- 临床发作特征和对通道阻断剂治疗的反应的比较.
主要成果:
- 在SCN1A组的患者中,发烧,长时间的发作和半克隆性半生物学更频繁.
- 在非SCN1A组中,发作聚类更常见.
- 通道阻塞剂在SCN1A组的72.4%中加剧了发作,但在非SCN1A组的63.3%中受益,在后者组中没有观察到恶化.
结论:
- 在SCN1A和非SCN1A婴儿发作的遗传之间存在不同的临床表现.
- 这些基因组之间对通道阻断剂的治疗反应有显著差异.
- 进一步的比较研究对于优化IOGE的管理策略至关重要.
更多相关视频
11:54Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
25.3K
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
20.2K
相关概念视频
Seizures: Classification
300
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
300
Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Antiepileptic Drugs: GABAergic Pathway Potentiators
321
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
321
